4.6 Article

Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity

Journal

EXPERIMENTAL CELL RESEARCH
Volume 336, Issue 1, Pages 100-108

Publisher

ELSEVIER INC
DOI: 10.1016/j.yexcr.2015.05.022

Keywords

Glucotoxicity; Lipotoxicity; GLP-1; L cells; Alpha cells; Beta cells

Funding

  1. University of Ulster selective research
  2. SAAD
  3. Department of Employment and Learning Research

Ask authors/readers for more resources

Knowledge of the effects of glucotoxic and lipotoxic environments on proglucagon producing intestinal L cells and pancreatic alpha cells is limited compared with pancreatic beta cells. This study compares the in vitro responses of these cell types to hyperglycaemia and hyperlipidaemia. Glucose (30 mM) and palmitate (0.5 mM) reduced GLUTag and MIN6 cell viability while alpha TC1 cells were sensitive only to lipotoxicity. Consistent with this, Cat mRNA expression was substantially higher in GLUTag and alpha TC1 cells compared to MIN6 cells. Glucose and palmitate reduced GLUTag cell secretory function while hypersecretion of glucagon was apparent from alpha TC1 cells. Glucose exposure increased transcription of Cat and Sod2 in MIN6 and GLUTag cells respectively while it decreased transcription of Cat and Gpx1 in alpha TC1 cells. Palmitate increased transcription of Cat and Sod2 in all three cell lines. Upregulation of antioxidant enzyme expression by palmitate was accompanied by an increase in Nfkb1 transcription, indicative of activation of defence pathways. Lipotoxicity activated ER stress response, evident from increased Hspa4 mRNA level in GLUTag and MIN6 cells. Glucose and palmitate-induced DNA damage and apoptosis, with substantially smaller effects in alpha TC1 cells. Thus alpha cells are resistant to gluco- and lipotoxicity, partly reflecting higher expression of genes involved in antioxidant defence. In contrast, intestinal L cells, like beta cells, are prone to gluco- and lipotoxicity, possibly contributing to abnormalities of GLP-1 secretion in type 2 diabetes. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice

Nupur M. Pathak, Paul J. B. Millar, Varun Pathak, Peter R. Flatt, Victor A. Gault

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)

Article Biochemistry & Molecular Biology

Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy

J. Michael Conlon, Milena Mechkarska, Yasser H. Abdel-Wahab, Peter R. Flatt

PEPTIDES (2018)

Review Biochemistry & Molecular Biology

Emerging role of GIP and related gut hormones in fertility and PCOS

R. Charlotte Moffett, Violetta Naughton

PEPTIDES (2020)

Article Pharmacology & Pharmacy

Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic α-cell transdifferentiation

Dipak Sarnobat, Charlotte R. Moffett, Neil Tanday, Frank Reimann, Fiona M. Gribble, Peter R. Flatt, Andrei I. Tarasov

BIOCHEMICAL PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Effects of long-acting analogues of lamprey GLP-1 and paddlefish glucagon on alpha- to beta-cell transdifferentiation in an insulin-deficient transgenic mouse model

Galyna Graham, J. Michael Conlon, R. Charlotte Moffett, Yasser H. Abdel-Wahab, Peter R. Flatt

Summary: The study showed that long-acting, dual-agonist anti-diabetic peptides can induce alpha-cell to beta-cell transdifferentiation, leading to increased pancreatic insulin content and plasma insulin concentrations. This suggests therapeutic potential for using proglucagon-derived peptides from phylogenetical ancient fish in diabetes treatment.

JOURNAL OF PEPTIDE SCIENCE (2021)

Article Endocrinology & Metabolism

Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations

D. Sarnobat, R. C. Moffett, P. R. Flatt, A. I. Tarasov

Summary: The study showed that metformin and rosiglitazone can help slow down the reduction of beta-cell pool in streptozotocin-induced diabetes, while tolbutamide may exacerbate beta-cell apoptosis but potentially protect beta-cells from chronic hyperglycemia by increasing insulin secretion directly.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Article Plant Sciences

Identification of Multiple Pancreatic and Extra-Pancreatic Pathways Underlying the Glucose-Lowering Actions of Acacia arabica Bark in Type-2 Diabetes and Isolation of Active Phytoconstituents

Prawej Ansari, Peter R. Flatt, Patrick Harriott, J. M. A. Hannan, Yasser H. A. Abdel-Wahab

Summary: The study demonstrated the antidiabetic effects of Acacia arabica bark extract, showing potential as a treatment for diabetes. The isolated phytoconstituents, including quercetin and kaempferol, improved glucose tolerance and insulin secretion, indicating the benefits of using them as antidiabetic agents.

PLANTS-BASEL (2021)

Article Multidisciplinary Sciences

Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats

Ananyaa Sridhar, Dawood Khan, Mahmoud Abdelaal, Jessie A. Elliott, Violetta Naughton, Peter R. Flatt, Carel W. Le Roux, Neil G. Docherty, Charlotte R. Moffett

Summary: Modification of gut-islet secretions after Roux-En-Y gastric bypass surgery contributes to its metabolic and anti-diabetic benefits. Limited knowledge exists on tissue-specific hormone distribution post-surgery and how it compares with medical treatment. This study provides insights into the cellular adaptations following surgery and medical treatment that contribute to the amelioration of obesity-diabetes phenotype in an animal model.

PLOS ONE (2022)

Article Medicine, Research & Experimental

NKCC transport mediates the insulinotropic effects of taurine and other small neutral amino acids

Julie Turbitt, Lorraine Brennan, R. Charlotte Moffett, Peter R. Flatt, Paul R. V. Johnson, Andrei I. Tarasov, Neville H. McClenaghan

Summary: The study found that taurine, alanine, and proline can promote insulin secretion through the regulation of ion transport and inhibition of the sodium-potassium-chloride cotransporter. This action of taurine may have potential value in the treatment of diabetes.

LIFE SCIENCES (2023)

Article Endocrinology & Metabolism

Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice

Vadivel Parthsarathy, Christopher Hogg, Peter R. Flatt, Finbarr P. M. O'Harte

DIABETES OBESITY & METABOLISM (2018)

Article Biochemistry & Molecular Biology

Locally produced xenin and the neurotensinergic system in pancreatic islet function and beta-cell survival

Dawood Khan, Srividya Vasu, R. Charlotte Moffett, Victor A. Gault, Peter R. Flatt, Nigel Irwin

BIOLOGICAL CHEMISTRY (2018)

No Data Available